Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apraglutide in Short Bowel Syndrome Associated With Intestinal Failure (SBS-IF)
NCT07742735Phase 3Recruiting
- Sponsor
- VectivBio
- Start
- Aug 2026
- Primary completion
- Oct 2028
- Countries
- 22
01
Overview
A Phase 3 trial of apraglutide in short bowel syndrome (SBS), sponsored by VectivBio. Started Aug 2026; status: recruiting.
02
Drugs
apraglutide
03
Conditions
short bowel syndrome (SBS)
Beyond the preview
Go deeper on NCT07742735.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07742735.